Alzamend Neuro News

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Apr 23 20:06 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Apr 3 17:05 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Apr 1 16:56 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Mar 28 16:36 ET

Alzamend Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MILTON C. AULT, III(40.3%),AULT ALLIANCE, INC.(25.4%), etc.

Feb 2 16:42 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Feb 2 16:31 ET

Alzamend Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MILTON C. AULT, III(29.4%),AULT LIFE SCIENCES, INC.(15.1%), etc.

Jan 25 17:26 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Jan 25 17:21 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Jan 9 00:00 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-10% Owner AULT MILTON C III

Dec 27, 2023 00:00 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Katzoff David J

Sep 26, 2023 18:01 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-10% Owner AULT MILTON C III

May 26, 2023 21:30 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Jackman Stephan

May 2, 2023 16:30 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director McGrath Lynne Fahey

Mar 23, 2023 16:30 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-10% Owner AULT MILTON C III

Mar 20, 2023 16:30 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities

Feb 28, 2023 16:30 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities

Feb 17, 2023 21:55 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities

Dec 29, 2022 06:00 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities

Dec 23, 2022 16:30 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities

Dec 20, 2022 16:30 ET